MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence [0.03%]
Mage-a3在癌症免疫治疗中的作用：临床和前期证据系统回顾
Gaurang Telang,Smriti Mishra,Anurag Sureshbabu et al.
Gaurang Telang et al.
Background: MAGE-A3, a cancer-testis antigen, is a promising immunotherapeutic target due to its high expression in various malignancies and limited expression in normal tissues. However, clinical outcomes with MAGE-A3-ba...
Patient reported outcomes for symptom toxicity in breast cancer patients undergoing radiotherapy [0.03%]
乳腺癌放射治疗患者的症状毒性患者报告结果
Nidhi Gupta,Aanchal Arora,Kislay Dimri et al.
Nidhi Gupta et al.
Background: Patient reported outcomes (PRO) usually report greater symptom toxicity compared to physician reported outcomes (PhyRO). In the present study, we measured PRO about symptom toxicity in breast cancer patients u...
Advances in breast cancer therapy: "Exploring the therapeutic potential of CDK 4/6 inhibitors and their clinical impact." [0.03%]
乳腺癌治疗进展：“探讨CDK 4/6抑制剂的治疗潜力及其临床影响”
Gayatri D Ambere,Devesh N Prajapati,Dyandevi Mathure et al.
Gayatri D Ambere et al.
One of the most common malignancies diagnosed globally is breast cancer, a condition that is impacted by both environmental and genetic causes, there are three distinct molecular subtypes of breast cancer: hormone receptor-positive (HR+), H...
Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillance [0.03%]
表观遗传学和其他生物标志物在上尿路尿路上皮癌诊断和监测中的作用
Gabriele Ricciardi,Pietro Tralongo,Vincenzo Fiorentino et al.
Gabriele Ricciardi et al.
Upper tract urothelial carcinoma (UTUC) is a rare but aggressive malignancy with increasing incidence, often diagnosed at advanced stages due to the limitations of current diagnostic tools. Conventional methods such as urinary cytology, ima...
Aleksandra Maciejczyk,Karol Bartecki,Anna M Czarnecka et al.
Aleksandra Maciejczyk et al.
Purpose: This review aims to evaluate the efficacy of hormonal therapy, including gonadotropin-releasing hormone agonists (GnRH agonists), aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs) and com...
Management of fertility preservation in young female patients with gastrointestinal cancer: A case series and systematic literature review [0.03%]
年轻女性胃肠道恶性肿瘤患者的生育力保存管理：病例系列和系统文献回顾
Gabriella Gentile,Mariavita Ciccarone
Gabriella Gentile
Gastrointestinal (GI) cancers in young women pose significant challenges to fertility due to the gonadotoxic effects of chemotherapy, radiotherapy, and surgical interventions. While fertility preservation options exist, counseling remains u...
Sensitivity of core needle biopsy in the diagnosis of lymphoma: A meta-analysis [0.03%]
空芯针穿刺活检诊断淋巴瘤敏感性的meta分析
Chloe Cottone,Katherine Kozlowski,Joshua Sorrentino et al.
Chloe Cottone et al.
Objective: Lymphoma commonly presents in the head and neck. Studies on the sensitivity of core needle biopsy (CNB) in diagnosing subtypes of lymphoma are mixed. We performed a meta-analysis of the existing literature to u...
Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literature [0.03%]
来那度胺治疗多发性骨髓瘤患者后继发急性淋巴细胞白血病两例及文献复习
Ozlem Candan,Derya Demirtas,Fatma Temiz et al.
Ozlem Candan et al.
Background: Lenalidomide, as an immunomodulatory drug, has significantly contributed to advancements in hematologic malignancies. However, lenalidomide therapy has been associated with rare but severe complications, parti...
Breast cancer neoadjuvant therapy outcome prediction based on clinical patient and tumor features: A cross-sectional study [0.03%]
基于临床患者和肿瘤特征的乳腺癌新辅助治疗结局预测：一项横断面研究
Eva Brenner,Luka Bulić,Marija Milković-Periša
Eva Brenner
Introduction: Breast cancer is the most common malignant disease in the female population and one of the most common diseases in developed countries. Many factors which may impact the development and outcome of this compl...
Won Jin Jeon,So Young Son,Faith Abodunrin et al.
Won Jin Jeon et al.
With recent breakthroughs in immunotherapy, particularly with the approval of immune checkpoint inhibitors for various cancer indications, patients now have a wider array of treatment options, even for those with metastatic disease. Still, ...